Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions
Identifieur interne : 007C97 ( Main/Exploration ); précédent : 007C96; suivant : 007C98Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions
Auteurs : K M J. Douglas [Royaume-Uni] ; E. Ladoyanni ; G J Treharne [Royaume-Uni] ; E D Hale [Royaume-Uni] ; N. Erb [Royaume-Uni] ; G D Kitas [Royaume-Uni]Source :
- Annals of the Rheumatic Diseases [ 0003-4967 ] ; 2006-10.
English descriptors
- KwdEn :
Abstract
Background: Cutaneous abnormalities are common in rheumatoid arthritis, but exact prevalence estimates are yet to be established. Some abnormalities may be independent and coincidental, whereas others may relate to rheumatoid arthritis or its treatment. Objectives: To determine the exact nature and point prevalence of cutaneous abnormalities in patients with rheumatoid arthritis compared with those in patients with non-inflammatory rheumatic disease. Methods: 349 consecutive outpatients for rheumatology (205 with rheumatoid arthritis and 144 with non-inflammatory rheumatic conditions) were examined for skin and nail signs by a dermatologist. Histories of rheumatology, dermatology, drugs and allergy were noted in detail. Results: Skin abnormalities were reported by more patients with rheumatoid arthritis (61%) than non-inflammatory controls (47%). More patients with rheumatoid arthritis (39%) than controls (10%) attributed their skin abnormality to drugs. Cutaneous abnormalities observed by the dermatologist were also more common in patients with rheumatoid arthritis (76%) than in the group with non-inflammatory disease (60%). Specifically, bruising, athlete’s foot, scars, rheumatoid nodules and vasculitic lesions were more common in patients with rheumatoid arthritis than in controls. The presence of bruising was predicted only by current steroid use. The presence of any other specific cutaneous abnormalities was not predicted by any of the variables assessed. In the whole group, current steroid use and having rheumatoid arthritis were the only important predictors of having any cutaneous abnormality. Conclusions: Self-reported and observed cutaneous abnormalities are more common in patients with rheumatoid arthritis than in controls with non-inflammatory disease. These include cutaneous abnormalities related to side effects of drugs or to rheumatoid arthritis itself and other abnormalities previously believed to be independent but which may be of clinical importance.
Url:
- https://api.istex.fr/document/E50A05768FAD5777EC1816B970B373C30CAEBAAD/fulltext/pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798318
DOI: 10.1136/ard.2005.048934
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 006B43
- to stream Istex, to step Curation: 006B43
- to stream Istex, to step Checkpoint: 001781
- to stream Pmc, to step Corpus: 001342
- to stream Pmc, to step Curation: 001341
- to stream Pmc, to step Checkpoint: 003C90
- to stream Ncbi, to step Merge: 002125
- to stream Ncbi, to step Curation: 002125
- to stream Ncbi, to step Checkpoint: 002125
- to stream Main, to step Merge: 007E90
- to stream Main, to step Curation: 007C97
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions</title>
<author><name sortKey="Douglas, K M J" sort="Douglas, K M J" uniqKey="Douglas K" first="K M J" last="Douglas">K M J. Douglas</name>
</author>
<author><name sortKey="Ladoyanni, E" sort="Ladoyanni, E" uniqKey="Ladoyanni E" first="E" last="Ladoyanni">E. Ladoyanni</name>
</author>
<author><name sortKey="Treharne, G J" sort="Treharne, G J" uniqKey="Treharne G" first="G J" last="Treharne">G J Treharne</name>
</author>
<author><name sortKey="Hale, E D" sort="Hale, E D" uniqKey="Hale E" first="E D" last="Hale">E D Hale</name>
</author>
<author><name sortKey="Erb, N" sort="Erb, N" uniqKey="Erb N" first="N" last="Erb">N. Erb</name>
</author>
<author><name sortKey="Kitas, G D" sort="Kitas, G D" uniqKey="Kitas G" first="G D" last="Kitas">G D Kitas</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E50A05768FAD5777EC1816B970B373C30CAEBAAD</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1136/ard.2005.048934</idno>
<idno type="url">https://api.istex.fr/document/E50A05768FAD5777EC1816B970B373C30CAEBAAD/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006B43</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006B43</idno>
<idno type="wicri:Area/Istex/Curation">006B43</idno>
<idno type="wicri:Area/Istex/Checkpoint">001781</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001781</idno>
<idno type="wicri:doubleKey">0003-4967:2006:Douglas K:cutaneous:abnormalities:in</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798318</idno>
<idno type="RBID">PMC:1798318</idno>
<idno type="wicri:Area/Pmc/Corpus">001342</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001342</idno>
<idno type="wicri:Area/Pmc/Curation">001341</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001341</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003C90</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003C90</idno>
<idno type="wicri:Area/Ncbi/Merge">002125</idno>
<idno type="wicri:Area/Ncbi/Curation">002125</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002125</idno>
<idno type="wicri:doubleKey">0003-4967:2006:Douglas K:cutaneous:abnormalities:in</idno>
<idno type="wicri:Area/Main/Merge">007E90</idno>
<idno type="wicri:Area/Main/Curation">007C97</idno>
<idno type="wicri:Area/Main/Exploration">007C97</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions</title>
<author><name sortKey="Douglas, K M J" sort="Douglas, K M J" uniqKey="Douglas K" first="K M J" last="Douglas">K M J. Douglas</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, West Midlands</wicri:regionArea>
<wicri:noRegion>West Midlands</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ladoyanni, E" sort="Ladoyanni, E" uniqKey="Ladoyanni E" first="E" last="Ladoyanni">E. Ladoyanni</name>
<affiliation><wicri:noCountry code="subField">Trust</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Treharne, G J" sort="Treharne, G J" uniqKey="Treharne G" first="G J" last="Treharne">G J Treharne</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Psychology, University of Birmingham, Birmingham</wicri:regionArea>
<placeName><settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
<settlement type="city">Birmingham</settlement>
</placeName>
<orgName type="university">Université de Birmingham</orgName>
</affiliation>
</author>
<author><name sortKey="Hale, E D" sort="Hale, E D" uniqKey="Hale E" first="E D" last="Hale">E D Hale</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, West Midlands</wicri:regionArea>
<wicri:noRegion>West Midlands</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Erb, N" sort="Erb, N" uniqKey="Erb N" first="N" last="Erb">N. Erb</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, West Midlands</wicri:regionArea>
<wicri:noRegion>West Midlands</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kitas, G D" sort="Kitas, G D" uniqKey="Kitas G" first="G D" last="Kitas">G D Kitas</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Dudley, West Midlands</wicri:regionArea>
<wicri:noRegion>West Midlands</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint><publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2006-10">2006-10</date>
<biblScope unit="volume">65</biblScope>
<biblScope unit="issue">10</biblScope>
<biblScope unit="page" from="1341">1341</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
<idno type="istex">E50A05768FAD5777EC1816B970B373C30CAEBAAD</idno>
<idno type="DOI">10.1136/ard.2005.048934</idno>
<idno type="href">annrheumdis-65-1341.pdf</idno>
<idno type="PMID">16476709</idno>
<idno type="local">0651341</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>DMARD, disease-modifying antirheumatic drug</term>
<term>NSAID, non-steroidal anti-inflammatory drug</term>
<term>SLE, systemic lupus erythematosus</term>
<term>TNF, tumour necrosis factor</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Cutaneous abnormalities are common in rheumatoid arthritis, but exact prevalence estimates are yet to be established. Some abnormalities may be independent and coincidental, whereas others may relate to rheumatoid arthritis or its treatment. Objectives: To determine the exact nature and point prevalence of cutaneous abnormalities in patients with rheumatoid arthritis compared with those in patients with non-inflammatory rheumatic disease. Methods: 349 consecutive outpatients for rheumatology (205 with rheumatoid arthritis and 144 with non-inflammatory rheumatic conditions) were examined for skin and nail signs by a dermatologist. Histories of rheumatology, dermatology, drugs and allergy were noted in detail. Results: Skin abnormalities were reported by more patients with rheumatoid arthritis (61%) than non-inflammatory controls (47%). More patients with rheumatoid arthritis (39%) than controls (10%) attributed their skin abnormality to drugs. Cutaneous abnormalities observed by the dermatologist were also more common in patients with rheumatoid arthritis (76%) than in the group with non-inflammatory disease (60%). Specifically, bruising, athlete’s foot, scars, rheumatoid nodules and vasculitic lesions were more common in patients with rheumatoid arthritis than in controls. The presence of bruising was predicted only by current steroid use. The presence of any other specific cutaneous abnormalities was not predicted by any of the variables assessed. In the whole group, current steroid use and having rheumatoid arthritis were the only important predictors of having any cutaneous abnormality. Conclusions: Self-reported and observed cutaneous abnormalities are more common in patients with rheumatoid arthritis than in controls with non-inflammatory disease. These include cutaneous abnormalities related to side effects of drugs or to rheumatoid arthritis itself and other abnormalities previously believed to be independent but which may be of clinical importance.</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Midlands de l'Ouest</li>
</region>
<settlement><li>Birmingham</li>
</settlement>
<orgName><li>Université de Birmingham</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Ladoyanni, E" sort="Ladoyanni, E" uniqKey="Ladoyanni E" first="E" last="Ladoyanni">E. Ladoyanni</name>
</noCountry>
<country name="Royaume-Uni"><noRegion><name sortKey="Douglas, K M J" sort="Douglas, K M J" uniqKey="Douglas K" first="K M J" last="Douglas">K M J. Douglas</name>
</noRegion>
<name sortKey="Erb, N" sort="Erb, N" uniqKey="Erb N" first="N" last="Erb">N. Erb</name>
<name sortKey="Hale, E D" sort="Hale, E D" uniqKey="Hale E" first="E D" last="Hale">E D Hale</name>
<name sortKey="Kitas, G D" sort="Kitas, G D" uniqKey="Kitas G" first="G D" last="Kitas">G D Kitas</name>
<name sortKey="Treharne, G J" sort="Treharne, G J" uniqKey="Treharne G" first="G J" last="Treharne">G J Treharne</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007C97 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007C97 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:E50A05768FAD5777EC1816B970B373C30CAEBAAD |texte= Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions }}
![]() | This area was generated with Dilib version V0.6.31. | ![]() |